Cargando…

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer

PURPOSE: To investigate the expression profile of systemic RNA interference deficient-1 transmembrane family member 1 (SIDT1) in patients with non-small cell lung cancer (NSCLC) and assess its prognostic value and immune infiltration. MATERIALS AND METHODS: A tissue microarray (TMA) was purchased co...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yubin, Zhou, Yong, Liu, Junhui, Yi, Lei, Gao, Zhaojia, Yuan, Kai, Tong, Jichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807869/
https://www.ncbi.nlm.nih.gov/pubmed/35125883
http://dx.doi.org/10.2147/IJGM.S347171
_version_ 1784643768730779648
author Tian, Yubin
Zhou, Yong
Liu, Junhui
Yi, Lei
Gao, Zhaojia
Yuan, Kai
Tong, Jichun
author_facet Tian, Yubin
Zhou, Yong
Liu, Junhui
Yi, Lei
Gao, Zhaojia
Yuan, Kai
Tong, Jichun
author_sort Tian, Yubin
collection PubMed
description PURPOSE: To investigate the expression profile of systemic RNA interference deficient-1 transmembrane family member 1 (SIDT1) in patients with non-small cell lung cancer (NSCLC) and assess its prognostic value and immune infiltration. MATERIALS AND METHODS: A tissue microarray (TMA) was purchased containing 60 paired NSCLC tissues and matched para-tumor tissues, and another TMA was constructed comprising 140 NSCLC tissues. Then, immunohistochemical staining and scoring were performed. Finally, we evaluated the expression profiles and prognostic values of SIDT1 in NSCLC. Correlation between SIDT1 gene expression and the immune microenvironment of NSCLC was investigated using the ESTIMATE and CIBERSORT algorithms. RESULTS: SIDT1 was mainly detected in the cytoplasm and the cell membrane. SIDT1 expression was significantly higher in tumor tissues than in para-tumor tissues. High expression of SIDT1 was correlated with the NSCLC stage. High SIDT1 expression signals worsening overall survival (OS) in NSCLC patients, especially in stage I. In LUSC, high SIDT1 expression is an independent prognostic factor for worsening OS. CONCLUSION: High SIDT1 expression predicted a low survival rate in LUSC patients, suggesting it may be a potential target for prognostic assessment of NSCLC patients.
format Online
Article
Text
id pubmed-8807869
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-88078692022-02-03 Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer Tian, Yubin Zhou, Yong Liu, Junhui Yi, Lei Gao, Zhaojia Yuan, Kai Tong, Jichun Int J Gen Med Original Research PURPOSE: To investigate the expression profile of systemic RNA interference deficient-1 transmembrane family member 1 (SIDT1) in patients with non-small cell lung cancer (NSCLC) and assess its prognostic value and immune infiltration. MATERIALS AND METHODS: A tissue microarray (TMA) was purchased containing 60 paired NSCLC tissues and matched para-tumor tissues, and another TMA was constructed comprising 140 NSCLC tissues. Then, immunohistochemical staining and scoring were performed. Finally, we evaluated the expression profiles and prognostic values of SIDT1 in NSCLC. Correlation between SIDT1 gene expression and the immune microenvironment of NSCLC was investigated using the ESTIMATE and CIBERSORT algorithms. RESULTS: SIDT1 was mainly detected in the cytoplasm and the cell membrane. SIDT1 expression was significantly higher in tumor tissues than in para-tumor tissues. High expression of SIDT1 was correlated with the NSCLC stage. High SIDT1 expression signals worsening overall survival (OS) in NSCLC patients, especially in stage I. In LUSC, high SIDT1 expression is an independent prognostic factor for worsening OS. CONCLUSION: High SIDT1 expression predicted a low survival rate in LUSC patients, suggesting it may be a potential target for prognostic assessment of NSCLC patients. Dove 2022-01-22 /pmc/articles/PMC8807869/ /pubmed/35125883 http://dx.doi.org/10.2147/IJGM.S347171 Text en © 2022 Tian et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tian, Yubin
Zhou, Yong
Liu, Junhui
Yi, Lei
Gao, Zhaojia
Yuan, Kai
Tong, Jichun
Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
title Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
title_full Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
title_fullStr Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
title_full_unstemmed Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
title_short Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
title_sort correlation of sidt1 with poor prognosis and immune infiltration in patients with non-small cell lung cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807869/
https://www.ncbi.nlm.nih.gov/pubmed/35125883
http://dx.doi.org/10.2147/IJGM.S347171
work_keys_str_mv AT tianyubin correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer
AT zhouyong correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer
AT liujunhui correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer
AT yilei correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer
AT gaozhaojia correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer
AT yuankai correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer
AT tongjichun correlationofsidt1withpoorprognosisandimmuneinfiltrationinpatientswithnonsmallcelllungcancer